Skip to search.
 TSX Down 0.17% TSX Ventures Down 0.39%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
447.52 Down 9.90(2.16%) Apr 17, 4:00PM EDT
|After Hours : 448.00 Up 0.48 (0.11%) Apr 17, 5:53PM EDT
Add to Portfolio
Prev Close:457.42
Open:451.58
Bid:365.27 x 100
Ask:453.20 x 100
1y Target Est:451.74
Beta:0.58
Next Earnings Date: 7-May-15REGN Earnings announcement
Day's Range:442.60 - 455.78
52wk Range:269.50 - 495.50
Volume:676,056
Avg Vol (3m):824,958
Market Cap:45.60B
P/E (ttm):145.77
EPS (ttm):3.07
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNDown 2.16%45.60B
AMGNDown 1.97%124.13B
NVSDown 0.82%245.76B
RHHBYDown 1.53%N/A

Key Statistics

Forward P/E (1 yr):35.46
P/S (ttm):16.53
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :10.79
Quarterly EPS Est (Mar-15) :2.70
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):2.25

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback